Geographic Atrophy Market, Global Outlook and Forecast 2022-2028

April 2022 | 63 pages | ID: GC938D7D2CCFEN
Market Monitor Global

Abstracts

Geographic atrophy (GA) is an advanced form of age-related macular degeneration (AMD) that causes a continuous progressive degeneration of the macula. The condition is characterized by widespread atrophy of the outer retinal tissue, retinal pigment epithelium, and choriocapillaris. It typically starts in the perifoveal region and develops to the fovea over time and causing central scotomas and permanent vision loss. Various drugs and treatments are under evaluation.

This report contains market size and forecasts of Geographic Atrophy in Global, including the following market information:

Global Geographic Atrophy Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Geographic Atrophy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Above 60 Years Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Geographic Atrophy include Apellis Pharmaceuticals, Iveric Bio, Alkeus Pharmaceuticals, Hemera Biosciences, Allegro Ophthalmics, Stealth BioTherapeutics, Gyroscope Therapeutics, Regenerative Patch Technologies and Roche, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Geographic Atrophy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Geographic Atrophy Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Geographic Atrophy Market Segment Percentages, by Type, 2021 (%)

• Above 60 Years
• Above 75 Years

Global Geographic Atrophy Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Geographic Atrophy Market Segment Percentages, by Application, 2021 (%)

• Late-stage (Phase III)
• Phase II
• Phase I
• Pre-clinical stage

Global Geographic Atrophy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Geographic Atrophy Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Geographic Atrophy revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Geographic Atrophy revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Apellis Pharmaceuticals
• Iveric Bio
• Alkeus Pharmaceuticals
• Hemera Biosciences
• Allegro Ophthalmics
• Stealth BioTherapeutics
• Gyroscope Therapeutics
• Regenerative Patch Technologies
• Roche
• Gensight Biologics
• NGM Biopharmaceuticals
• AstraZeneca
• Lineage Cell Therapeutics
• Allergan

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Geographic Atrophy Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Geographic Atrophy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL GEOGRAPHIC ATROPHY OVERALL MARKET SIZE

2.1 Global Geographic Atrophy Market Size: 2021 VS 2028
2.2 Global Geographic Atrophy Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Geographic Atrophy Players in Global Market
3.2 Top Global Geographic Atrophy Companies Ranked by Revenue
3.3 Global Geographic Atrophy Revenue by Companies
3.4 Top 3 and Top 5 Geographic Atrophy Companies in Global Market, by Revenue in 2021
3.5 Global Companies Geographic Atrophy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Geographic Atrophy Players in Global Market
  3.6.1 List of Global Tier 1 Geographic Atrophy Companies
  3.6.2 List of Global Tier 2 and Tier 3 Geographic Atrophy Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Geographic Atrophy Market Size Markets, 2021 & 2028
  4.1.2 Above 60 Years
  4.1.3 Above 75 Years
4.2 By Type - Global Geographic Atrophy Revenue & Forecasts
  4.2.1 By Type - Global Geographic Atrophy Revenue, 2017-2022
  4.2.2 By Type - Global Geographic Atrophy Revenue, 2023-2028
  4.2.3 By Type - Global Geographic Atrophy Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Geographic Atrophy Market Size, 2021 & 2028
  5.1.2 Late-stage (Phase III)
  5.1.3 Phase II
  5.1.4 Phase I
  5.1.5 Pre-clinical stage
5.2 By Application - Global Geographic Atrophy Revenue & Forecasts
  5.2.1 By Application - Global Geographic Atrophy Revenue, 2017-2022
  5.2.2 By Application - Global Geographic Atrophy Revenue, 2023-2028
  5.2.3 By Application - Global Geographic Atrophy Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Geographic Atrophy Market Size, 2021 & 2028
6.2 By Region - Global Geographic Atrophy Revenue & Forecasts
  6.2.1 By Region - Global Geographic Atrophy Revenue, 2017-2022
  6.2.2 By Region - Global Geographic Atrophy Revenue, 2023-2028
  6.2.3 By Region - Global Geographic Atrophy Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Geographic Atrophy Revenue, 2017-2028
  6.3.2 US Geographic Atrophy Market Size, 2017-2028
  6.3.3 Canada Geographic Atrophy Market Size, 2017-2028
  6.3.4 Mexico Geographic Atrophy Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Geographic Atrophy Revenue, 2017-2028
  6.4.2 Germany Geographic Atrophy Market Size, 2017-2028
  6.4.3 France Geographic Atrophy Market Size, 2017-2028
  6.4.4 U.K. Geographic Atrophy Market Size, 2017-2028
  6.4.5 Italy Geographic Atrophy Market Size, 2017-2028
  6.4.6 Russia Geographic Atrophy Market Size, 2017-2028
  6.4.7 Nordic Countries Geographic Atrophy Market Size, 2017-2028
  6.4.8 Benelux Geographic Atrophy Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Geographic Atrophy Revenue, 2017-2028
  6.5.2 China Geographic Atrophy Market Size, 2017-2028
  6.5.3 Japan Geographic Atrophy Market Size, 2017-2028
  6.5.4 South Korea Geographic Atrophy Market Size, 2017-2028
  6.5.5 Southeast Asia Geographic Atrophy Market Size, 2017-2028
  6.5.6 India Geographic Atrophy Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Geographic Atrophy Revenue, 2017-2028
  6.6.2 Brazil Geographic Atrophy Market Size, 2017-2028
  6.6.3 Argentina Geographic Atrophy Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Geographic Atrophy Revenue, 2017-2028
  6.7.2 Turkey Geographic Atrophy Market Size, 2017-2028
  6.7.3 Israel Geographic Atrophy Market Size, 2017-2028
  6.7.4 Saudi Arabia Geographic Atrophy Market Size, 2017-2028
  6.7.5 UAE Geographic Atrophy Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Apellis Pharmaceuticals
  7.1.1 Apellis Pharmaceuticals Corporate Summary
  7.1.2 Apellis Pharmaceuticals Business Overview
  7.1.3 Apellis Pharmaceuticals Geographic Atrophy Major Product Offerings
  7.1.4 Apellis Pharmaceuticals Geographic Atrophy Revenue in Global Market (2017-2022)
  7.1.5 Apellis Pharmaceuticals Key News
7.2 Iveric Bio
  7.2.1 Iveric Bio Corporate Summary
  7.2.2 Iveric Bio Business Overview
  7.2.3 Iveric Bio Geographic Atrophy Major Product Offerings
  7.2.4 Iveric Bio Geographic Atrophy Revenue in Global Market (2017-2022)
  7.2.5 Iveric Bio Key News
7.3 Alkeus Pharmaceuticals
  7.3.1 Alkeus Pharmaceuticals Corporate Summary
  7.3.2 Alkeus Pharmaceuticals Business Overview
  7.3.3 Alkeus Pharmaceuticals Geographic Atrophy Major Product Offerings
  7.3.4 Alkeus Pharmaceuticals Geographic Atrophy Revenue in Global Market (2017-2022)
  7.3.5 Alkeus Pharmaceuticals Key News
7.4 Hemera Biosciences
  7.4.1 Hemera Biosciences Corporate Summary
  7.4.2 Hemera Biosciences Business Overview
  7.4.3 Hemera Biosciences Geographic Atrophy Major Product Offerings
  7.4.4 Hemera Biosciences Geographic Atrophy Revenue in Global Market (2017-2022)
  7.4.5 Hemera Biosciences Key News
7.5 Allegro Ophthalmics
  7.5.1 Allegro Ophthalmics Corporate Summary
  7.5.2 Allegro Ophthalmics Business Overview
  7.5.3 Allegro Ophthalmics Geographic Atrophy Major Product Offerings
  7.5.4 Allegro Ophthalmics Geographic Atrophy Revenue in Global Market (2017-2022)
  7.5.5 Allegro Ophthalmics Key News
7.6 Stealth BioTherapeutics
  7.6.1 Stealth BioTherapeutics Corporate Summary
  7.6.2 Stealth BioTherapeutics Business Overview
  7.6.3 Stealth BioTherapeutics Geographic Atrophy Major Product Offerings
  7.6.4 Stealth BioTherapeutics Geographic Atrophy Revenue in Global Market (2017-2022)
  7.6.5 Stealth BioTherapeutics Key News
7.7 Gyroscope Therapeutics
  7.7.1 Gyroscope Therapeutics Corporate Summary
  7.7.2 Gyroscope Therapeutics Business Overview
  7.7.3 Gyroscope Therapeutics Geographic Atrophy Major Product Offerings
  7.7.4 Gyroscope Therapeutics Geographic Atrophy Revenue in Global Market (2017-2022)
  7.7.5 Gyroscope Therapeutics Key News
7.8 Regenerative Patch Technologies
  7.8.1 Regenerative Patch Technologies Corporate Summary
  7.8.2 Regenerative Patch Technologies Business Overview
  7.8.3 Regenerative Patch Technologies Geographic Atrophy Major Product Offerings
  7.8.4 Regenerative Patch Technologies Geographic Atrophy Revenue in Global Market (2017-2022)
  7.8.5 Regenerative Patch Technologies Key News
7.9 Roche
  7.9.1 Roche Corporate Summary
  7.9.2 Roche Business Overview
  7.9.3 Roche Geographic Atrophy Major Product Offerings
  7.9.4 Roche Geographic Atrophy Revenue in Global Market (2017-2022)
  7.9.5 Roche Key News
7.10 Gensight Biologics
  7.10.1 Gensight Biologics Corporate Summary
  7.10.2 Gensight Biologics Business Overview
  7.10.3 Gensight Biologics Geographic Atrophy Major Product Offerings
  7.10.4 Gensight Biologics Geographic Atrophy Revenue in Global Market (2017-2022)
  7.10.5 Gensight Biologics Key News
7.11 NGM Biopharmaceuticals
  7.11.1 NGM Biopharmaceuticals Corporate Summary
  7.11.2 NGM Biopharmaceuticals Business Overview
  7.11.3 NGM Biopharmaceuticals Geographic Atrophy Major Product Offerings
  7.11.4 NGM Biopharmaceuticals Geographic Atrophy Revenue in Global Market (2017-2022)
  7.11.5 NGM Biopharmaceuticals Key News
7.12 AstraZeneca
  7.12.1 AstraZeneca Corporate Summary
  7.12.2 AstraZeneca Business Overview
  7.12.3 AstraZeneca Geographic Atrophy Major Product Offerings
  7.12.4 AstraZeneca Geographic Atrophy Revenue in Global Market (2017-2022)
  7.12.5 AstraZeneca Key News
7.13 Lineage Cell Therapeutics
  7.13.1 Lineage Cell Therapeutics Corporate Summary
  7.13.2 Lineage Cell Therapeutics Business Overview
  7.13.3 Lineage Cell Therapeutics Geographic Atrophy Major Product Offerings
  7.13.4 Lineage Cell Therapeutics Geographic Atrophy Revenue in Global Market (2017-2022)
  7.13.5 Lineage Cell Therapeutics Key News
7.14 Allergan
  7.14.1 Allergan Corporate Summary
  7.14.2 Allergan Business Overview
  7.14.3 Allergan Geographic Atrophy Major Product Offerings
  7.14.4 Allergan Geographic Atrophy Revenue in Global Market (2017-2022)
  7.14.5 Allergan Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Geographic Atrophy Market Opportunities & Trends in Global Market
Table 2. Geographic Atrophy Market Drivers in Global Market
Table 3. Geographic Atrophy Market Restraints in Global Market
Table 4. Key Players of Geographic Atrophy in Global Market
Table 5. Top Geographic Atrophy Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Geographic Atrophy Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Geographic Atrophy Revenue Share by Companies, 2017-2022
Table 8. Global Companies Geographic Atrophy Product Type
Table 9. List of Global Tier 1 Geographic Atrophy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Geographic Atrophy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Geographic Atrophy Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Geographic Atrophy Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Geographic Atrophy Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Geographic Atrophy Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Geographic Atrophy Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Geographic Atrophy Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Geographic Atrophy Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Geographic Atrophy Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Geographic Atrophy Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Geographic Atrophy Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Geographic Atrophy Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Geographic Atrophy Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Geographic Atrophy Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Geographic Atrophy Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Geographic Atrophy Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Geographic Atrophy Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Geographic Atrophy Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Geographic Atrophy Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Geographic Atrophy Revenue, (US$, Mn), 2023-2028
Table 30. Apellis Pharmaceuticals Corporate Summary
Table 31. Apellis Pharmaceuticals Geographic Atrophy Product Offerings
Table 32. Apellis Pharmaceuticals Geographic Atrophy Revenue (US$, Mn), (2017-2022)
Table 33. Iveric Bio Corporate Summary
Table 34. Iveric Bio Geographic Atrophy Product Offerings
Table 35. Iveric Bio Geographic Atrophy Revenue (US$, Mn), (2017-2022)
Table 36. Alkeus Pharmaceuticals Corporate Summary
Table 37. Alkeus Pharmaceuticals Geographic Atrophy Product Offerings
Table 38. Alkeus Pharmaceuticals Geographic Atrophy Revenue (US$, Mn), (2017-2022)
Table 39. Hemera Biosciences Corporate Summary
Table 40. Hemera Biosciences Geographic Atrophy Product Offerings
Table 41. Hemera Biosciences Geographic Atrophy Revenue (US$, Mn), (2017-2022)
Table 42. Allegro Ophthalmics Corporate Summary
Table 43. Allegro Ophthalmics Geographic Atrophy Product Offerings
Table 44. Allegro Ophthalmics Geographic Atrophy Revenue (US$, Mn), (2017-2022)
Table 45. Stealth BioTherapeutics Corporate Summary
Table 46. Stealth BioTherapeutics Geographic Atrophy Product Offerings
Table 47. Stealth BioTherapeutics Geographic Atrophy Revenue (US$, Mn), (2017-2022)
Table 48. Gyroscope Therapeutics Corporate Summary
Table 49. Gyroscope Therapeutics Geographic Atrophy Product Offerings
Table 50. Gyroscope Therapeutics Geographic Atrophy Revenue (US$, Mn), (2017-2022)
Table 51. Regenerative Patch Technologies Corporate Summary
Table 52. Regenerative Patch Technologies Geographic Atrophy Product Offerings
Table 53. Regenerative Patch Technologies Geographic Atrophy Revenue (US$, Mn), (2017-2022)
Table 54. Roche Corporate Summary
Table 55. Roche Geographic Atrophy Product Offerings
Table 56. Roche Geographic Atrophy Revenue (US$, Mn), (2017-2022)
Table 57. Gensight Biologics Corporate Summary
Table 58. Gensight Biologics Geographic Atrophy Product Offerings
Table 59. Gensight Biologics Geographic Atrophy Revenue (US$, Mn), (2017-2022)
Table 60. NGM Biopharmaceuticals Corporate Summary
Table 61. NGM Biopharmaceuticals Geographic Atrophy Product Offerings
Table 62. NGM Biopharmaceuticals Geographic Atrophy Revenue (US$, Mn), (2017-2022)
Table 63. AstraZeneca Corporate Summary
Table 64. AstraZeneca Geographic Atrophy Product Offerings
Table 65. AstraZeneca Geographic Atrophy Revenue (US$, Mn), (2017-2022)
Table 66. Lineage Cell Therapeutics Corporate Summary
Table 67. Lineage Cell Therapeutics Geographic Atrophy Product Offerings
Table 68. Lineage Cell Therapeutics Geographic Atrophy Revenue (US$, Mn), (2017-2022)
Table 69. Allergan Corporate Summary
Table 70. Allergan Geographic Atrophy Product Offerings
Table 71. Allergan Geographic Atrophy Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Geographic Atrophy Segment by Type in 2021
Figure 2. Geographic Atrophy Segment by Application in 2021
Figure 3. Global Geographic Atrophy Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Geographic Atrophy Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Geographic Atrophy Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Geographic Atrophy Revenue in 2021
Figure 8. By Type - Global Geographic Atrophy Revenue Market Share, 2017-2028
Figure 9. By Application - Global Geographic Atrophy Revenue Market Share, 2017-2028
Figure 10. By Region - Global Geographic Atrophy Revenue Market Share, 2017-2028
Figure 11. By Country - North America Geographic Atrophy Revenue Market Share, 2017-2028
Figure 12. US Geographic Atrophy Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Geographic Atrophy Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Geographic Atrophy Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Geographic Atrophy Revenue Market Share, 2017-2028
Figure 16. Germany Geographic Atrophy Revenue, (US$, Mn), 2017-2028
Figure 17. France Geographic Atrophy Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Geographic Atrophy Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Geographic Atrophy Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Geographic Atrophy Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Geographic Atrophy Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Geographic Atrophy Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Geographic Atrophy Revenue Market Share, 2017-2028
Figure 24. China Geographic Atrophy Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Geographic Atrophy Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Geographic Atrophy Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Geographic Atrophy Revenue, (US$, Mn), 2017-2028
Figure 28. India Geographic Atrophy Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Geographic Atrophy Revenue Market Share, 2017-2028
Figure 30. Brazil Geographic Atrophy Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Geographic Atrophy Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Geographic Atrophy Revenue Market Share, 2017-2028
Figure 33. Turkey Geographic Atrophy Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Geographic Atrophy Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Geographic Atrophy Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Geographic Atrophy Revenue, (US$, Mn), 2017-2028
Figure 37. Apellis Pharmaceuticals Geographic Atrophy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Iveric Bio Geographic Atrophy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Alkeus Pharmaceuticals Geographic Atrophy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Hemera Biosciences Geographic Atrophy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Allegro Ophthalmics Geographic Atrophy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Stealth BioTherapeutics Geographic Atrophy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Gyroscope Therapeutics Geographic Atrophy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Regenerative Patch Technologies Geographic Atrophy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Roche Geographic Atrophy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Gensight Biologics Geographic Atrophy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. NGM Biopharmaceuticals Geographic Atrophy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. AstraZeneca Geographic Atrophy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Lineage Cell Therapeutics Geographic Atrophy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Allergan Geographic Atrophy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)